Global Brand Marketing Senior Director Aesthetics

SUMMARY OF THE POSITION

The Global Brand Marketing Director Aesthetics is responsible for defining the strategic brand foundation that will shape Ipsen’s entry into the global aesthetics market. This role builds the brand architecture, positioning, messaging, and competitive differentiation for Ipsen’s aesthetics portfolio in preparation of a potential Aesthetic launch — ensuring that the scientific innovation behind a recombinant neuro‑inhibitor and the IPN10200 molecule is translated into a compelling, clearly differentiated global brand.

Working in close partnership with the VP Global Head of Marketing Aesthetics, the Director develops how Ipsen’s aesthetics brand is articulated and experienced across healthcare professionals, injectors, consumers, industry stakeholders, and the broader aesthetics ecosystem within Ipsen’s operation regions. The role ensures that brand strategy connects both scientific rigor and emotional resonance, grounding differentiation in product attributes, mechanism of action, clinical outcomes, and user‑valued aesthetic benefits.

A central responsibility is shaping how Ipsen defines and claims a new competitive space in a crowded neurotoxin landscape — establishing the strategic and narrative foundations for the category entry of a next‑generation recombinant molecule. This includes developing global messaging frameworks, points of differentiation, value propositions, and the clear articulation of what makes Ipsen’s Aesthetic offering distinct, relevant, and a must-have in a highly competitive environment.

The Director leads the development of the strategic storytelling and communications architecture that supports global launch readiness, scientific storytelling, pipeline visibility, advocacy engagement, and long‑term franchise equity building. This encompasses the development of core global brand assets, creative platforms, and launch messaging that can be adopted and localized by Ipsen’s markets.

Operating at the intersection of brand strategy, scientific translation, creative development, and stakeholder engagement, the Director ensures that Ipsen’s aesthetics story is consistently expressed through differentiated, insight‑driven narratives that reinforce clinical credibility, aesthetic desirability, and long‑term commercial differentiation.

MAIN RESPONSIBILITIES

1. Global Brand Strategy & Architecture

• Define and own the global brand architecture for Ipsen’s aesthetics portfolio, including brand purpose, positioning, and long‑term brand vision.

• Establish a clear, differentiated brand platform that translates scientific innovation into a compelling aesthetic value proposition.

• Ensure the brand architecture is scalable and future‑proof, supporting portfolio expansion and lifecycle evolution.

2. Brand Positioning, Messaging & Competitive Differentiation

• Develop the global positioning and messaging strategy for Ipsen’s aesthetics portfolio, grounded in product attributes, mechanism of action, clinical data, and user‑valued aesthetic benefits.

• Shape how Ipsen defines and claims a new competitive space in a crowded neurotoxin landscape, articulating clear points of differentiation for a new‑generation recombinant neuro inhibitor and the corabotase molecule.

• Build global value propositions and messaging frameworks that clearly articulate what makes Ipsen’s offering distinct, relevant, and superior for healthcare professionals, injectors, and consumers.

3. Scientific Translation & Strategic Storytelling

• Translate complex scientific and clinical innovation into clear, credible, and compelling brand narratives (reason to try, reason to switch, reason to purchase).

• Lead the development of franchise‑level storytelling that connects scientific rigor with emotional and aspirational dimensions of aesthetics.

• Ensure consistency between scientific evidence, medical positioning, and brand expression across all touchpoints.

4. Global Launch Readiness & Brand Activation Framework

• Lead the development of the brand components of global launch strategy, ensuring readiness across positioning, messaging, creative platforms, and core assets.

• Define global brand playbooks, messaging hierarchies, and creative frameworks that enable effective localization by regions and markets across Ipsen’s operation regions

• Partner with global and priority markets to support launch planning, adaptation, and execution within defined brand guardrails.

5. Creative Platform & Asset Development

• Lead the development of global creative platforms, brand identity elements, tone of voice, and storytelling frameworks.

• Oversee the creation of core global brand assets, launch materials, and messaging toolkits across HCP, injector, and consumer‑facing contexts.

• Manage creative and branding agency partners to ensure excellence, consistency, and efficiency.

6. Stakeholder Engagement & Cross‑Functional Collaboration

• Work closely with the VP Global Head of Marketing Aesthetics to ensure brand strategy aligns with overall franchise strategy.

• Partner with Medical Affairs, R&D, Regulatory, and Legal to ensure brand positioning and messaging are evidence‑based, compliant, and credible.

• Collaborate with Corporate Affairs and Digital teams to ensure alignment between franchise storytelling and Ipsen’s broader corporate narrative, while retaining ownership of brand strategy and launch‑related messaging.

7. Insight‑Driven Brand Development

• Leverage physician, injector, and consumer insights to inform brand strategy, messaging, and creative direction.

• Monitor competitive dynamics and evolving trends within the aesthetics and beauty ecosystem to continuously sharpen differentiation.

8. Franchise Equity & Long‑Term Value Creation

• Build and protect long‑term franchise brand equity through consistent storytelling, differentiated positioning, and disciplined execution.

• Support pipeline visibility and lifecycle evolution through cohesive narrative development and brand continuity.

• Ensure brand strategy contributes directly to long‑term commercial differentiation and sustainable growth of the Aesthetics franchise.

KNOWLEDGE & EXPERIENCE

Knowledge & Experience (essential):

• 12–15+ years of experience in global brand strategy, brand marketing, or strategic communications within medical aesthetics, medical devices, consumer health, luxury goods or adjacent innovation‑driven categories.

• Proven experience working in medical aesthetics, consumer healthcare, luxury goods or competitive, B2B2C environments, where brand differentiation, messaging clarity, and stakeholder perception directly impact commercial success.

• Strong understanding of the aesthetics ecosystem, including injector and physician dynamics, consumer motivations, aesthetic trends, and the influence of cultural and digital signals on demand and perception.

• Demonstrated track record building brand architecture, positioning, and messaging frameworks that clearly differentiate products in crowded categories.

• Ability to translate complex scientific innovation (e.g., mechanism of action, clinical outcomes, novel modalities) into compelling, compliant, and accessible brand narratives.

• Experience shaping new or emerging category spaces, defining points of differentiation and value propositions for next‑generation products.

• Experience operating in global, cross‑functional environments, partnering closely with Marketing, Medical Affairs, R&D, Regulatory, Legal, and Commercial teams.

• Proven involvement in global product launches, including development of brand strategy, launch messaging, and global toolkits.

• Strong experience managing external agencies and creative partners, including brand, creative, and research agencies.

Education / Certifications (essential):

• Advanced degree in Marketing, Business, Economics, Life Sciences or related discipline.

• MBA or equivalent business qualification preferred

Language(s) (essential):

• English (fluent – spoken and written)

Language(s) (preferred):

• Additional languages an advantage

#LI-Hybrid